The STAR 3 study - A prospective, randomized, two-arm study to compare the efficacy of the MiniMed Paradigm REAL-Time System versus multiple daily injections (MDI) in subjects naive to insulin pump therapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin aspart; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms STAR 3
- 23 May 2018 Biomarkers information updated
- 22 Sep 2010 Results for paediatric patients were presented in an abstract at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 21 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD).